Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Oncogenomics
  • Published:

Hyperexpression of locus C genes in the HOX network is strongly associated in vivo with human bladder transitional cell carcinomas

Oncogene volume 22, pages 6462–6468 (2003)Cite this article

Abstract

Bladder carcinogenesis remains unclear despite the identification of chemical, environmental and genetic factors. It has recently been reported that the chromosomal region 12q13–q15, containing crucial cancer genes such as MDM2, CDK4 and GLI, is amplified in bladder cancer. In the same region are also located the genes of the locus HOX C, flanked by keratin genes whose protein product may be a prognostic marker of bladder cancer. The HOX genes constitute a network of transcription factors controlling embryonal development and play an important role in crucial adult eukaryotic cell functions. The molecular organization of this 39-gene network is unique in the genome and probably acts by regulating phenotypical cell identity. We have analysed the expression of the whole HOX gene network in pairs of normal–tumour bladder and in tumoral biopsies. Comparison between normal urothelium and bladder tumour has identified dramatic variations of expression in a block of three genes (HOX C4, HOX C5 and HOX C6) localized in the HOX C locus on the chromosome 12q13 and in the paralogous group 11 HOX genes, involved during normal development in the formation of the urogenital system. These data suggest a key involvement of the HOX gene network, and especially the locus C, in bladder cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  • Abate-Shen C . (2002). Nat. Rev. Cancer, 2, 777–785.

  • Adshead JM, Ogden CW, Penny MA, Stuart ET and Kessling AM . (1999). BJU Int., 83, 1039–1044.

  • Akam M . (1987). Development, 101, 1–22.

  • Apiou F, Flagiello D, Cillo C, Malfoy B, Poupon MF and Dutrillaux B . (1996). Cytogenet. Cell Genet., 73, 114–115.

  • Cantile M, Pettinato G, Procino A, Feliciello I, Cindolo L and Cillo C . (2003a). Eur. J. Cancer, 39, 257–264.

  • Cantile M, Procino A, D'Armiento M, Cindolo L and Cillo C . (2003b). J. Cell. Physiol., 194, 225–236.

  • Chirgwin JM, Przybyla AE, MacDonald RJ and Rutter WJ . (1979). Biochemistry, 18, 5294–5299.

  • Christoph F, Schmidt B, Schmitz-Drager BJ and Schulz WA . (1999). Int. J. Cancer, 84, 169–173.

  • Cillo C . (1994–95). Invas. Metastasis, 14, 38–49.

  • Cillo C, Barba P, Freschi G, Bucciarelli G, Magli MC and Boncinelli E . (1992). Int. J. Cancer, 51, 892–897.

  • Cillo C, Cantile M, Faiella A and Boncinelli E . (2001). J. Cell. Physiol., 188, 161–169.

  • Cillo C, Cantile M, Mortarini R, Barba P, Parmiani G and Anichini A . (1996). Int. J. Cancer, 66, 692–697.

  • Cillo C, Cantile M, Mortarini R, Tiberio C, Barba P, Anichini A and Poupon MF . (1995a). Proceedings 86° AACR-abs. 3358.

  • Cillo C, Wilmore HP, Barba P and Brown KW . (1995b). Int. J. Oncol., 7, 1145–1150.

  • Cordon-Cardo C . (1998). Cancer Surv., 32, 115–131.

  • Davis AP and Capecchi MR . (1994). Development, 120, 2187–2198.

  • Davis AP, Witte DP, Hsieh-Li HM, Potter S and Capecchi M . (1995). Nature, 375, 791–795.

  • Dekker EJ, Pannese M, Houtzager E, Timmermans A, Boncinelli E and Durston A . (1992). Development (Suppl.) 195–202.

  • Duboule D and Morata G . (1994). Trends Genet., 10, 358–364.

  • Favier B, Le Meur M, Chambon P and Dollé P . (1994). Proc. Natl. Acad. Sci. USA, 92, 310–314.

  • Ferber S, Halkin A, Cohen H, Ber I, Einav Y, Goldberg I, Barshack I, Seijffers R, Kopolovic J, Kaiser N and Karasik A . (2000). Nat. Med., 6, 568–572.

  • Fujimoto K, Yamada Y, Okajima E, Kakizoe T, Sasaki H, Sugimura T and Terada M . (1992). Cancer Res., 52, 1393–1398.

  • Gazzaniga P, Gradilone A, Frati L and Agliano AM . (2001). Clin. Cancer Res., 7, 4288–4289.

  • Gehring WJ and Hiromi Y . (1986). Annu. Rev. Genet., 20, 147–173.

  • Graham A, Papalopulu N and Krumlauf R . (1989). Cell, 57, 367–378.

  • Gromova I, Gromov P and Celis JE . (1999). Electrophoresis, 20, 241–248.

  • Hostikka SL and Capecchi MR . (1998). Mech. Dev., 70, 133–145.

  • Hu G, Lee H, Price SM, Shen MM and Abate-Shen C . (2001). Development, 12, 2373–2384.

  • Jave-Suarez LF, Winter H, Langbein L, Rogers MA and Schweizer J . (2002). J. Biol. Chem., 277, 3718–3726.

  • Jones SN, Sands AT, Hancock AR, Vogel H, Donehower LA, Linke SP, Wahl GM and Bradley A . (1996). Proc. Natl. Acad. Sci. USA, 93, 14106–14111.

  • Kinzler KW, Bigner SH, Bigner DD, Trent JM, Law ML, O'Brien SJ, Wong AJ and Vogelstein B . (1987). Science, 236, 70–73.

  • Lander ES . et al. (2001). Nature, 409, 860–921.

  • Lussier M, Filion M, Compton JG, Nadeau JH, Lapointe L and Royal A . (1990). Gene, 95, 203–213.

  • Magli, MC, Barba P, Celetti A, De Vita G, Cillo C and Boncinelli E . (1991). Proc. Natl. Acad. Sci. USA, 88, 6348–6352.

  • Moll R, Achtstatter T, Becht E, Balcarova-Stander J, Ittensohn M and Franke WW . (1988). Am. J. Pathol., 132, 123–144.

  • Moll R, Franke WW, Schiller DL, Geiger B and Krepler R . (1982). Cell, 31, 11–24.

  • Mortlock DP and Innis JW . (1997). Nat. Genet., 15, 179–180.

  • Nakamura T, Largaespada DA, Lee MP, Johnson LA, Ohyashiki K, Toyama K, Chen SJ, Willman CL, Chen IM, Feinberg AP, Jenkins NA, Copeland NG and Shaughnessy Jr JD . (1996). Nat. Genet., 12, 154–158.

  • Nilsson M, Unden AB, Krause D, Malmqwist U, Raza K, Zaphiropoulos PG and Toftgard R . (2000). Proc. Natl. Acad. Sci. USA, 97, 3438–3443.

  • Nocito A, Konenen J, Kallioniemi OP and Sauter G . (2001). Int. J. Cancer, 94, 1–5.

  • Raman V, Martensen SA, Reisman D, Evron E, Odenwald WF, Jaffee E, Marks J and Sukumar S . (2000). Nature, 405, 974–978.

  • Reed SI . (1997). Cancer Surv., 29, 7–23.

  • Sandberg AA . (2002). Am. J. Med. Genet., 115, 173–182.

  • Scott MP . (1992). Cell, 71, 551–553.

  • Shinohara N and Koyanagi T . (2002). Urol. Res., 30, 273–281.

  • Simeone A, Pannese M, Acampora D, D'Esposito M and Boncinelli E . (1988). Nucleic Acids Res., 16, 5379–5390.

  • Simon R, Richter J, Wagner U, Fijan A, Bruderer J, Schmid U, Ackermann D, Maurer R, Alund G, Knonagel H, Rist M, Wilber K, Anabitarte M, Hering F, Hardmeier T, Schonenberger A, Flury R, Jager P, Fehr JL, Mihatsch MJ, Gasser T and Sauter G . (2001). Cancer Res., 61, 4514–4519.

  • Simon R, Struckmann K, Schraml P, Wagner U, Forster T, Moch H, Fijan A, Bruderer J, Wilber K, Mihatsch MJ, Gasser T and Sauter G . (2002). Oncogene, 21, 2476–2483.

  • Spitz F, Gonzales F and Duboule D . (2003). Cell, 113, 405–418.

  • Small KM and Potter SS . (1993). Genes Dev., 7, 2318–2328.

  • Wada T, Louhelainen J, Hemminki K, Adolfsson J, Wijkstrom H, Norming U, Borgstrom E, Hansson J, Sandstedt B and Steineck G . (2000). Clin. Cancer Res., 6, 610–615.

  • Walterhouse D, Ahmed M, Slusarski D, Kalamaras J, Boucher D, Holmgren R and Iannaccone P . (1993). Dev. Dyn., 196, 91–102.

  • Wolfel T, Hauer M, Schneider J, Serrano M, Wolfel C, Klehmann-Hieb E, De Plaen E, Hankeln T, Meyer zum Buschenfelde KH and Beach D . (1995). Science, 269, 1281–1284.

  • UICC (1997). TNM Classificationof Malignant Tumors, 5th edn. Wiley-Liss: New York.

  • Yoon SJ, LeBlanc-Straceski J, Ward D, Krauter K and Kucherlapati R . (1994). Genomics, 24, 502–508.

Download references

Acknowledgements

We thank L Terracciano for his critical reading of the manuscript and A. Procino for the helpful participation in this project. CC acknowledges the financial support of MURST 2001 projects.

Author information

Authors and Affiliations

  1. Department of Clinical and Experimental Medicine, Federico II University Medical School, Via S. Pansini 5, Naples, 80131, Italy

    Monica Cantile & Clemente Cillo

  2. Department of Urology, Federico II University Medical School, Via S. Pansini 5, Naples, 80131, Italy

    Luca Cindolo, Giorgio Napodano & Vincenzo Altieri

Authors
  1. Monica Cantile
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luca Cindolo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giorgio Napodano
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vincenzo Altieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Clemente Cillo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Clemente Cillo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cantile, M., Cindolo, L., Napodano, G. et al. Hyperexpression of locus C genes in the HOX network is strongly associated in vivo with human bladder transitional cell carcinomas. Oncogene 22, 6462–6468 (2003). https://doi.org/10.1038/sj.onc.1206808

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206808

Keywords

This article is cited by

Search

Advanced search

Quick links